Prolactin cell carcinoma of the pituitary. Clinicopathologic, immunohistochemical, and ultrastructural study of a case with cranial and extracranial metastases
- PMID: 3965110
- DOI: 10.1002/1097-0142(19850201)55:3<598::aid-cncr2820550320>3.0.co;2-s
Prolactin cell carcinoma of the pituitary. Clinicopathologic, immunohistochemical, and ultrastructural study of a case with cranial and extracranial metastases
Abstract
A patient with a primary adenohypophyseal neoplasm who had a long course marked by multiple surgical resections, radiation therapy, and high-dose dopamine agonist therapy developed local invasion as well as cranial and extracranial osseous metastatic lesions. The serum prolactin levels were greatly elevated, and immunohistochemical studies demonstrated prolactin in the cytoplasm of primary and metastatic tumor cells. Ultrastructural features of lactotrophic differentiation, including misplaced granule exocytosis, were observed. This is the third reported case of prolactin cell carcinoma that metastasized despite high-dose dopamine agonist therapy. Analysis of the patient's serum prolactin showed no abnormality in the chromatographic profile of biologic activity.
Similar articles
-
Effect of bromocriptine and pergolide on pituitary tumor size and serum prolactin.AJNR Am J Neuroradiol. 1983 May-Jun;4(3):415-7. AJNR Am J Neuroradiol. 1983. PMID: 6410759 Free PMC article. Clinical Trial.
-
Discordant responses of prolactinoma to two different dopamine agonists.Clin Endocrinol (Oxf). 1986 Apr;24(4):421-6. doi: 10.1111/j.1365-2265.1986.tb01647.x. Clin Endocrinol (Oxf). 1986. PMID: 3742834
-
Reduction in size of prolactin-secreting tumours in men treated with pergolide.Br Med J (Clin Res Ed). 1982 Aug 14;285(6340):465-7. doi: 10.1136/bmj.285.6340.465. Br Med J (Clin Res Ed). 1982. PMID: 6809126 Free PMC article.
-
Prolactin-secreting carcinoma of the pituitary: clinicopathological and immunohistochemical study of a case with intracranial and intraspinal dissemination.Br J Neurosurg. 1997 Aug;11(4):350-5. doi: 10.1080/02688699746177. Br J Neurosurg. 1997. PMID: 9337937 Review.
-
Diagnosis and drug therapy of prolactinoma.Drugs. 1996 Jun;51(6):954-65. doi: 10.2165/00003495-199651060-00004. Drugs. 1996. PMID: 8736617 Review.
Cited by
-
Progression on metastatic neuroendocrine carcinoma from a recurrent prolactinoma: a case report.J Clin Pathol. 2002 Feb;55(2):148-51. doi: 10.1136/jcp.55.2.148. J Clin Pathol. 2002. PMID: 11865014 Free PMC article. Review.
-
Prolactin secreting pituitary carcinoma.J Neurol Neurosurg Psychiatry. 1992 Dec;55(12):1205-6. doi: 10.1136/jnnp.55.12.1205. J Neurol Neurosurg Psychiatry. 1992. PMID: 1479402 Free PMC article.
-
An Institutional Experience of Tumor Progression to Pituitary Carcinoma in a 15-Year Cohort of 1055 Consecutive Pituitary Neuroendocrine Tumors.Endocr Pathol. 2019 Jun;30(2):118-127. doi: 10.1007/s12022-019-9568-5. Endocr Pathol. 2019. PMID: 30706322
-
The biology and pathology of selected skull base tumors.J Neurooncol. 1994;20(3):213-40. doi: 10.1007/BF01053041. J Neurooncol. 1994. PMID: 7844620 Review.
-
Intracranial dissemination of pituitary adenoma. Case report and review of the literature.Ital J Neurol Sci. 1994 May;15(4):195-200. doi: 10.1007/BF02339323. Ital J Neurol Sci. 1994. PMID: 7960673 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical